Posts
Possible buyout $vwav $svre
Enterprise Value (EV) Baseline: As of mid-2026, SaverOne’s raw Enterprise Value sits at approximately $89.9 million. This factors in its equity, total debts, and available cash. An outright corporate buyout of SaverOne 2014 Ltd. (Nasdaq: SVRE) is estimated to cost between $110 million and $175 million, depending on the acquisition …
Get In NOW! This Stock will make millionaires by 2029
$FVRR - the market is valuing a cash machine at almost nothing Lead with the balance sheet, because it's absurd. Market cap: \~$400M Net cash: \~$280M (roughly 70% of the entire market cap is just sitting in the bank) Enterprise value: \~$140M FY2025 free cash flow: \~$104M Read that again. …
🗞️ QSEGF news
Yooo So first major sale from a globally renowned financial company in malaysia 🔥 Hate when they don’t say what company though ( i understand why just hate they don’t) Honestly was just posting to vent i feel like its the start of a validation that QSE does qork and …
embecta -EMBC ✅
Deadline August 5. Buyback-100 mln $$$. EMBC is starting to look more and more interesting. Institutional filings continue to come in, and several funds have increased their positions despite the stock trading near multi-year lows. The $100 million share repurchase authorization remains in place, and if the company has already …
YHC! Where my alckies at! Can you tell me what pattern this is?
I'd like to ask Jim, Jack and Jose if it'd be wise to throw some extra cash at YHC. I'm calling it the L pattern that could turn into a U pattern if you drink enough LQR. Just did a reverse split. Does it have a fighting chance? Does anyone …
SonicStrategy (CAN $SONI : USA: $SONIF) AI Infrastructure Entry: How It Works + New Data Center / Compute Revenue Model
They're transitioning from **blockchain validator/staking ops** into **decentralized AI compute** via the ARKLAB AI asset acquisition. Here's the breakdown: # 1. How They're Getting In (The "Add-Ins" / Entry Mechanism) * **The Deal**: Non-binding LOI to acquire proprietary **software + IP** from ARKLAB AI. This isn't buying a full company …
Spero Therapeutics Changing focus
Spero Therapeutics has purchased an asset from Innovent Biologics, a Chinese biotech/pharma that has relationships already with Pfizer and Lilly among others. To do this, they monetized future royalty payments from GSK on their Tebipenem Hbr asset. Stock is down today based on this change in direction/focus. Spero monetized the …
THE EARNINGS REPORT IS HERE , WHAT ARE YOU BUYING
# 🏦 Big bank earnings officially kicked off earnings season Major banks including: * JPMorgan Chase * Goldman Sachs * Bank of America * Citigroup reported quarterly results. **Highlights** * Goldman Sachs impressed investors with stronger-than-expected earnings. * Several banks benefited from solid trading and investment banking revenue. * Investors …
14 JULY 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
# 📉 Top Losers (Under $5) |Ticker|Price|% Loss|Likely Catalyst| |:-|:-|:-|:-| |**USDE**|$3.70|**-60.64%**|Heavy selling pressure after a sharp prior run-up. | |**CELZ**|$1.20|**-40.00%**|Profit-taking and biotech sector weakness. | |**LICN**|$1.02|**-38.92%**|Small-cap Chinese stock volatility. | |**TVRD**|$1.50|**-36.44%**|Selling after recent speculative gains. | |**UBXG**|$4.28|**-32.06%**|High-volume selloff with no major positive catalyst. | # 🔥 Stocks worth watching These …
14 JULY 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
# 🚀 Top Gainers |Ticker|Price|% Gain|Likely Catalyst| |:-|:-|:-|:-| |**GMM**|$4.57|**+147.03%**|Heavy speculative buying, unusually high trading volume. | |**JZXN**|$2.17|**+85.47%**|Momentum trade with very high volume. | |**ZBAO**|$0.42|**+43.18%**|Strong retail interest and speculative buying. | |**YMAT**|$2.44|**+28.42%**|Increased buying activity following recent market interest. | |**LGHL**|$2.94|**+34.71%**|Unusually high volume drove the stock higher. | # 🔥 Stocks worth …